| | | CD57/B3gat1 Protein, Human, Recombinant (mFc)
RHC-CD-3335
61.7 kDa (predicted)
+¦-1, 3-glucuronyltransferase 1, NK-1, NK1, LEU7, HNK1, GLCUATP, GLCATP, CD57, beta-1, 3-glucuronyltransferase 1 CD59 Protein, Human, Recombinant (hFc)
RHC-CD-0584
35.73 kDa (predicted). Due to glycosylation, the p
MSK21, MIRL, MIN3, MIN2, MIN1, MIC11, MEM43, MAC-IP, MACIP, MACIF, HRF-20, HRF20, G344, CD59, 1F5 CD59 Protein, Human, Recombinant (His)
RHC-CD-0649
10.2 kDa (predicted); 13-19 kDa (reducing conditio
p18-20, MSK21, MIRL, MIN3, MIN2, MIN1, MIC11, MGC2354, MEM43, MAC-IP, MACIF, HRF-20, HRF20, G344, FLJ92039, FLJ38134, EL32, EJ30, EJ16, CD59 molecule, 1F5, 16.3A5 CD5L Protein, Human, Recombinant (His)
RHC-CD-3536
37.5 kDa (predicted); 45 kDa (reducing condition,
SP-+¦, Sp+¦, SP-ALPHA, Spalpha, PRO229, CD5 molecule-like, API6, AIM CD5L Protein, Mouse, Recombinant (His)
RHC-CD-3588
38 kDa (predicted); 55-60 kDa (reducing condition,
Sp-+¦, Sp-alpha, Pdp, CT2, CD5 molecule-like, Api6, AI047839, AAC-11, 42010 CD64 Protein, Human, Recombinant (His & Avi)
RHC-RP-1918
33.5 kDa (predicted). Due to glycosylation, the pr
IGFR1, FLJ18345, Fc-+¦ RIA, FcRIA, FCRI, Fcr, FcgRI, FCGR1A, FCGR1, Fcgr, Fc-gamma RIA, FCG1, FcERI, FCE1A, Fc +¦ RI/CD64, Fc +¦ RI, Fc gamma RI, CD64a, CD64 CD64 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2144
33.5 kDa (predicted). Due to glycosylation, the pr
IGFR1, FLJ18345, Fc-+¦ RIA, FcRIA, FCRI, Fcr, FcgRI, FCGR1A, FCGR1, Fcgr, Fc-gamma RIA, FCG1, FcERI, FCE1A, Fc +¦ RI/CD64, Fc +¦ RI, Fc gamma RI, CD64a, CD64 CD64 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-2487
34.3 kDa (predicted); 50-55 kDa (reducing conditio
IGGHAFC, Fc+¦RI, FcgammaRI, Fc receptor, IgG, high affinity I, CD64, AV092959, AI323638 CD64 Protein, Mouse, Recombinant (His)
RHC-CD-2085
32 kDa (predicted); 45-50 kDa (reducing condition,
IGGHAFC, Fc+¦RI, FcgammaRI, Fc receptor, IgG, high affinity I, CD64, AV092959, AI323638 CD69 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0252
16.91 kDa (predicted). Due to glycosylation, the p
P26, MLR-3, Leu 23, GP32, EA1, CLEC2C, CD69, BL-AC/P26, BL-AC, AIM, 28 CD73 Protein, Human, Recombinant (hFc)
RHC-CD-1343
84.5 kDa (predicted)
NTE, NT5, NT, eNT, eN, E5NT, CD73, CALJA, 5-nucleotidase, ecto (CD73) CD73 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1295
61.04 kDa (predicted); 60.6 kDa (reducing conditio
NTE, NT5, NT, eNT, eN, E5NT, CD73, CALJA, 5-nucleotidase, ecto (CD73) CD73 Protein, Human, Recombinant (His)
RHC-CD-1316
59.2 kDa (predicted)
NTE, NT5, NT, eNT, eN, E5NT, CD73, CALJA, 5-nucleotidase, ecto (CD73) CD74 Protein, Mouse, Recombinant (His)
RHC-CD-0095
26.82 kDa (predicted); 43.61 kDa (reducing conditi
Ii, Ia-+¦, Ia-GAMMA, HLADG, DHLAG, CLIP, CD74 molecule, major histocompatibility complex, class II invariant chain CD79 Protein, Mouse, Recombinant (His)
RHC-CD-0126
30.3 kDa (predicted); 34.6, 28.3 and 24.1 kDa (red
mb-1, Ly-54, Ly54, Ig-+¦, Ig+¦, Ig-alpha, Igalpha, Iga, CD79a molecule, immunoglobulin-associated +¦, CD79a molecule, immunoglobulin-associated alpha CD79A Protein, Mouse, Recombinant (hFc)
RHC-CD-0246
39 kDa (predicted)
mb-1, Ly-54, Ly54, Ig-+¦, Ig+¦, Ig-alpha, Igalpha, Iga, CD79a molecule, immunoglobulin-associated +¦, CD79a molecule, immunoglobulin-associated alpha CD79B Protein, Human, Recombinant (hFc)
RHC-CD-0315
45-65 kDa (reducing condition)
Immunoglobulin-Associated B29 Protein, Ig-+¦, Ig-Beta, IGB, CD79b, B-Cell-Specific Glycoprotein B29, B-Cell Antigen Receptor Complex-Associated Protein +¦ Chain, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, B29 CD79B Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0107
30-40 kDa (reducing condition)
Immunoglobulin-Associated B29 Protein, Ig-+¦, Ig-Beta, IGB, CD79b, B-Cell-Specific Glycoprotein B29, B-Cell Antigen Receptor Complex-Associated Protein +¦ Chain, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, B29 CD79B Protein, Mouse, Recombinant (hFc)
RHC-CD-0316
50-65 kDa (reducing condition)
Immunoglobulin-Associated B29 Protein, Ig-+¦, Ig-Beta, IGB, CD79b, B-Cell-Specific Glycoprotein B29, B-Cell Antigen Receptor Complex-Associated Protein +¦ Chain, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, B29 CD79B Protein, Mouse, Recombinant (His)
RHC-CD-0029
16.4 kDa (predicted); 25-35 kDa (reducing conditio
Ig-+¦, Ig+¦, Ig-beta, Igbeta, Igb, CD79b molecule, immunoglobulin-associated +¦, CD79b molecule, immunoglobulin-associated beta, B29 CD79B Protein, Rhesus macaque, Recombinant (hFc)
RHC-CD-0187
50-60 kDa (reducing condition)
Immunoglobulin-Associated B29 Protein, Ig-+¦, Ig-Beta, IGB, CD79b, B-Cell-Specific Glycoprotein B29, B-Cell Antigen Receptor Complex-Associated Protein +¦ Chain, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, B29 CD8 alpha Protein, Human, Recombinant (aa 22-182, His & Avi), Biotinylated
RHC-CD-2451
20.5 kDa (predicted). Due to glycosylation, the pr
p32, OKT8 T-cell antigen, MAL, Lyt-2, Leu2, CD8a molecule, CD8a, CD8 +¦/CD8A, CD8 CD8 alpha Protein, Human, Recombinant (hFc)
RHC-CD-2154
44.3 kDa (predicted)
p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 +¦, CD8 alpha, CD8 CD8 alpha Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2323
20.87 kDa (predicted); 29.7 kDa (reducing conditio
p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 +¦, CD8 alpha, CD8 CD8 alpha Protein, Human, Recombinant (His)
RHC-CD-2195
19 kDa (predicted); 28 kDa (reducing condition, du
p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 +¦, CD8 alpha, CD8 CD8 alpha Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2194
19 kDa (predicted); 28 kDa (reducing condition, du
p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 +¦, CD8 alpha, CD8 CD82 Protein, Human, Recombinant (hFc)
RHC-CD-1375
40-60 kDa (reducing condition)
TSPAN274F9, Tspan-27, TSPAN27, Tetraspanin-27, Suppressor of tumorigenicity 6 protein, ST6tspan-27, ST6, KAI1GR15, KAI1, Inducible membrane protein R2, IA4C33 antigen, IA4, CD82 molecule, CD82 antigenC33, CD82 CD82 Protein, Human, Recombinant (His)
RHC-CD-1783
15 kDa (predicted); 25-33 kDa (reducing condition,
TSPAN27, ST6, SAR2, R2, KAI-1, KAI1, IA4, GR15, CD82 molecule, C33, 4F9 CD86 Protein, Mouse, Recombinant (hFc)
RHC-CD-0230
52 kDa (predicted)
TS/A-2, MB7-2, MB7, Ly-58, Ly58, ETC-1, CLS1, CD86 antigen, Cd28l2, B7-2, B70, B7.2, B7 CD86 Protein, Mouse, Recombinant (His)
RHC-CD-0120
26.8 kDa (predicted); 40-55 kDa (reducing conditio
TS/A-2, MB7-2, MB7, Ly-58, Ly58, ETC-1, CLS1, CD86 antigen, Cd28l2, B7-2, B70, B7.2, B7 CD86 Protein, Mouse, Recombinant (His), Biotinylated
RHC-CD-0289
26.7 kDa (predicted)
TS/A-2, MB7-2, MB7, Ly-58, Ly58, ETC-1, CLS1, CD86 antigen, Cd28l2, B7-2, B70, B7.2, B7 CD9 Protein, Human, Recombinant (hFc)
RHC-CD-2891
34-38 kDa (reducing condition)
TSPAN29, MRP1, MIC3, DRAP-27, Cell growth-inhibiting gene 2 protein, CD9 molecule, CD9 antigen, CD9, BTCC1 CD93/C1qR1 Protein, Human, Recombinant (hFc)
RHC-CD-0082
85.2 kDa (predicted); 125 kDa (reducing condition,
MXRA4, ECSM3, dJ737E23.1, CDw93, CD93 molecule, C1qRP, C1QR1, C1qR(P), C1qR CD93/C1qR1 Protein, Human, Recombinant (His&Avi), Biotinylated
RHC-CD-0155
61.2 kDa (predicted). Due to glycosylation, the pr
MXRA4, ECSM3, dJ737E23.1, CDw93, CD93, C1qRp, C1QR1, C1qR(p), C1qR, C1q/MBL/SPA receptor CD93/C1qR1 Protein, Human, Recombinant (His)
RHC-CD-0212
59.6 kDa (predicted); 100 kDa (reducing condition,
MXRA4, ECSM3, dJ737E23.1, CDw93, CD93 molecule, C1qRP, C1QR1, C1qR(P), C1qR CD98 Protein, Human, Recombinant (His)
RHC-CD-1782
49.2 kDa (predicted); 65-75 kDa (reducing conditio
solute carrier family 3 (amino acid transporter heavy chain), member 2, NACAE, MDU1, CD98HC, CD98, 4T2HC, 4F2HC, 4F2 CD98 Protein, Human, Recombinant (His), Biotinylated
RHC-CD-1741
49.19 kDa (predicted); 70.72 kDa (reducing conditi
solute carrier family 3 (amino acid transporter heavy chain), member 2, NACAE, MDU1, CD98HC, CD98, 4T2HC, 4F2HC, 4F2 CD98 Protein, Mouse, Recombinant (His)
RHC-CD-1311
49.2 kDa (predicted); 60-70 kDa (reducing conditio
solute carrier family 3 (amino acid transporter heavy chain), member 2, NACAE, Mgp-2hc, Mdu1, Ly-m10, Ly-10, Ly10, Cd98, AI314110, 4F2HC, 4F2 CDDO METHYL ESTER
CAS:218600-53-4
Trade Name: methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6
Formula: C32H43NO4
APS218600534
505.69 CDH11 Protein, Human, Recombinant (aa 54-617, His)
RHC-CD-3217
66.32 kDa (predicted). Due to glycosylation, the p
Osteoblast cadherin, OSF-4, OB-cadherin, OB, CDHOB, CDH11, Cadherin-11, CAD11OSF-4 CDH17 Protein, Cynomolgus, Recombinant (His)
RHC-RP-0101
89.2 kDa (predicted). Due to glycosylation, the pr
P130, MGC142024, MGC138218, LI-cadherin, HPT-1, FLJ26931, Cdh17, CDH16, Cadherin-17, cadherin-16, BILL-cadherin CDH3 Protein, Cynomolgus, Recombinant (His)
RHC-RP-0001
61.11 kDa (predicted). Due to glycosylation, the p
Placental cadherin, PCADP-cadherin, P-cadherin, PCAD, HJMD, CDHP, CDH3, Cadherin-3, CAD3 CDH3 Protein, Human, Recombinant (aa 108-654, His)
RHC-RP-0176
64.32 kDa (predicted). Due to glycosylation, the p
Placental cadherin, PCADP-cadherin, P-cadherin, PCAD, HJMD, CDHP, CDH3, Cadherin-3, CAD3 CDK1 Protein, Human, Recombinant (His)
RHC-ENZY-0951
38.1 kDa (predicted)
P34CDC2, p34 protein kinase, Cyclin-dependent kinase 1, Cell division protein kinase 1, Cell division control protein 2 homolog, CDKN1, CDK1, CDC28A, CDC2 CDK1/2 INHIBITOR III
CAS:443798-55-8
Trade Name: 5-amino-N-(2,6-difluorophenyl)-3-(4-sulfamoylanilino)-1,2,4-triazole-1-carbothioamide
Formula: C15H13F2N7O2S2
ACM443798558
425.4
Cdk1/2 Inhibitor III, 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE, 5-Amino-3-((4-(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, 2wu6, AC1NS9OB CDK5 Protein, Human, Recombinant
RHC-ENZY-1180
33.4 kDa (predicted)
TPKII catalytic subunit, Tau protein kinase II catalytic subunit, Serine/threonine-protein kinase PSSALRE, PSSALRE, Cyclin-dependent-like kinase 5, Cyclin-dependent kinase 5, Cell division protein kinase 5, CDKN5, CDK5 CDK7 Protein, Human, Recombinant
RHC-ENZY-0796
39.2 kDa (predicted)
TFIIH basal transcription factor complex kinase subunit, STK1, Serine/threonine-protein kinase 1, p39 Mo15, MO15, Cyclin-dependent kinase 7, Cell division protein kinase 7, CDKN7, CDK-activating kinase 1, CDK7, CAK1, CAK, 39 kDa protein kin CDK7 Protein, Human, Recombinant (His)
RHC-ENZY-0988
41.5 kDa (predicted)
TFIIH basal transcription factor complex kinase subunit, STK1, Serine/threonine-protein kinase 1, p39 Mo15, MO15, Cyclin-dependent kinase 7, Cell division protein kinase 7, CDKN7, CDK-activating kinase 1, CDK7, CAK1, CAK, 39 kDa protein kin CDK9 INHIBITOR II
CAS:140651-18-9
Trade Name: 4-[(3,5-diamino-1H-pyrazol-4-yl)hydrazinylidene]cyclohexa-2,5-dien-1-one
Formula: C9H10N6O
ACM140651189
218.2
Cdk9 Inhibitor II, CHEMBL1823556, 4-(3,5-Diamino-1H-pyrazol-4-ylazo)-phenol, 4-[(E)-(3,5-Diamino-1h-Pyrazol-4-Yl)diazenyl]phenol, 140651-18-9, F18, 2clx, 3tn8, SureCN3310182, SureCN12589685, UNII-ZG0O47K626, CAN508, CHEMBL215205, CTK8F0280, CDKI
CAS:70035-83-5
Trade Name: 2,4-diaminopyrimidin-5-ol
Formula: C4H6N4O??-+xHCl
ACM70035835
126.12 (free base ba
2,4-Diaminopyrimidin-5-ol, 70035-83-5, 5-Pyrimidinol, 2,4-diamino-, 2,4-DIAMINO-PYRIMIDIN-5-OL, AG-G-73321, SureCN338978, AGN-PC-00L0Y0, CTK2H5372, MolPort-003-980-620, ANW-67022, AKOS006339628, NCGC00165766-01, AK-90064, KB-225444 CEACAM1 Protein, Mouse, Recombinant (hFc)
RHC-RP-0262
70.3 kDa (predicted)
mmCGM2, mmCGM1a, mmCGM1, MHVR1, MHVR, Mhv-1, mCEA1, Hv-2, Hv2, Cea-7, Cea7, Cea-1, Cea1, CD66a, C-CAM, Cc1, carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein), Bgp1, Bgp, bb-1 CEACAM1 Protein, Mouse, Recombinant (His)
RHC-RP-0190
45 kDa (predicted); 70-100 kDa (reducing condition
mmCGM2, mmCGM1a, mmCGM1, MHVR1, MHVR, Mhv-1, mCEA1, Hv-2, Hv2, Cea-7, Cea7, Cea-1, Cea1, CD66a, C-CAM, Cc1, carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein), Bgp1, Bgp, bb-1 CEACAM5 Protein, Cynomolgus, Recombinant (aa 35-685, His)
RHC-CD-2956
72.76 kDa (predicted). Due to glycosylation, the p
Meconium antigen 100, DKFZp781M2392, CEACD66e, CEACAM-5, CEA, CD66e, Carcinoembryonic CEANOTHIC ACID
CAS:21302-79-4
Trade Name: (1R,2R,5S,8R,9R,10R,13R,14R,15R,16S,18R)-16-hydroxy-1,2,14,17,17-pentamethyl-8-prop-1-en-2-ylpentacy
Formula: C30H46O5
FFC-AR-21302794
486.68
2+¦-Carboxy-3+¦-hydroxy-A(1)-nor-5+¦-lupan-20(29)-en-28-oic acid CEANOTHIC ACID ACETATE
CAS:119533-63-0
Trade Name: (1R,2R,5S,8R,9R,10R,13R,14R,15R,16S,18R)-16-acetyloxy-1,2,14,17,17-pentamethyl-8-prop-1-en-2-ylpenta
Formula: C32H48O6
ACM119533630
528.7 Cedramber
CAS:67874-81-1
Trade Name: (1S,2R,5S,7R,8R)-8-Methoxy-2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecane
FFC67874811
236.39
(3R,3aS,6R,7R,8aS)-Octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene CEDRENOL
CAS:28231-03-0
Formula: C15H24O
ACM28231030
220.35
1H-3a,7-Methanoazulen-5-ol, octahydro-3,8,8-trimethyl-6-methylene-;7-methanoazulen-5-ol,octahydro-3,8,8-trimethyl-6-methylene-1h-3;7-Methanoazulen-5-ol,octahydro-3,8,8-trimethyl-6-methylene-1H-3a;7-methanoazulen-5-ol,octahydro-6-methylene-3 CEDRENYL ACETATE
CAS:1405-92-1
Formula: C17H28O2
ACM1405921
[3R-(3alpha,3abeta,7beta,8aalpha)]-2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-1H-3a,7-methanoazulene-6-methyl acetate;1H-3a,7-Methanoazulene-6-methanol, 2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-, acetate, (3R,3aS,7R,8aS)-;[3R-(3alpha,3abeta,7beta CEDROL
CAS:77-53-2
Trade Name: (1S,2R,5S,7R,8R)-2,6,6,8-Tetramethyltricyclo[5.3.1.01,5]undecan-8-ol
Formula: C15H26O
CI-SC-1215
222.37 g/mol
(1S,2R,5S,7R,8R)-2,6,6,8-Tetramethyltricyclo[5.3.1.0]undecan-8-ol CEDROL FORMATE
CAS:39900-38-4
Trade Name: [(1S,2R,5S,7R,8R)-2,6,6,8-Tetramethyl-8-tricyclo[5.3.1.01,5]undecanyl] formate
FFC39900384
250.38
7-Methanoazulen-6-ol,octahydro-3,6,8,8-tetramethyl-,formate,(3R,3aS,6R,7R,8aS)-1H-3a CEDRYL FORMATE
CAS:39900-38-4
Formula: C16H26O2
ACM39900384
250.38
CEDRENYL FORMATE;CEDRYL FORMATE;1h-3a,7-methanoazulen-6-ol,octahydro-3,6,8,8-tetramethyl-,formate,[3theta-(;1h-3-alpha,7-methanoazulen-6-ol,octahydro-3,6,8,8-tetramethyl-,formate,(3r-(;3a-beta,6-alpha,7-beta,8a-alpha))-3-alph;3abeta,6alpha, CEDRYL METHYL ETHER
CAS:67874-81-1
Formula: C16H28O
ACM67874811
236.396
[3R-(3alpha,3abeta,6alpha,7beta,8aalpha)]-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene;CEDROLMETHYLESTER;(3R-(3alpha,3Abeta,6alpha,7beta,8aalpha))-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3A,7-methanoazulene;1H-3A,7-Meth CEFACLOR
CAS:53994-73-3
Trade Name: (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-
Formula: C15H14ClN3O4S
APS53994733
367.81
Kefral, Distaclor, Losefar, Alfacet, Ceclor MR, Cefaclor, Panoral, S 6472, Ceclor, 7-(D-2-Amino-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylic acid,5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-phenylacetyl]am |
